In Vitro and In Vivo Evaluation of the Antifungal Activity of APX001A/APX001 against Candida auris
Open accessThe DOI matches its Crossref record; the references it cites are not checked yet.
Abstract
Candida auris is an emerging multidrug-resistant yeast that has been responsible for invasive infections associated with high morbidity and mortality. C. auris strains often demonstrate high fluconazole and amphotericin B MIC values, and some strains are resistant to all three major antifungal classes. We evaluated the susceptibility of 16 C. auris clinical strains, isolated from a wide geographical area, to 10 antifungal agents, including APX001A, a novel agent that inhibits the fungal protein Gwt1 (glycosylphosphatidylinositol-anchored wall transfer protein 1). APX001A demonstrated significantly lower MIC 50 and MIC 90 values (0.004 and 0.031 μg/ml, respectively) than all other agents tested. The efficacy of the prodrug APX001 was evaluated in an immunocompromised murine model of disseminated C. auris infection. Significant efficacy (80 to 100% survival) was observed in all three APX001 treatment groups versus 50% survival for the anidulafungin treatment group. In addition, APX001 showed a significant log reduction in CFU counts in kidney, lung, and brain tissue (1.03 to 1.83) versus the vehicle control. Anidulafungin also showed a significant log reduction in CFU in the kidneys and lungs (1.5 and 1.62, respectively) but did not impact brain CFU. These data support further clinical evaluation of this new antifungal agent.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“APX001 was shown to be active against C. auris in vitro”
From Treatment of Invasive Candidiasis: A Narrative Review (2018) · cites this paper as [118]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Broad-spectrum antifungal activity has been observed against pathogenic yeasts and molds, including activity against resistant strains (16–18).”
From Clinical Efficacy and Safety of a Novel Antifungal, Fosmanogepix, in Patients with Candidemia Caused by Candida auris : Results from a Phase 2 Trial (2023) · cites this paper as [16]
The cited source says what the claim attributes to it.
In the citing paper
“and increased the survival of C. auris infected mice (80% to 100% survival versus 50% survival with anidulafungin) [118]”
From Treatment of Invasive Candidiasis: A Narrative Review (2018) · cites this paper as [118]
In the citing paper
“Fosmanogepix possesses broad in vitro activity against many genera of fungi: Candida (excluding C. krusei), Trichosporon, Coccidioides, Cryptococcus, Aspergillus (A. fumigatus, A. flavus, A. niger), as well as AmB-resistant strains of Fusarium and Scedosporium (Fig. 1) [51, 53–55].”
From Investigational Agents for the Treatment of Resistant Yeasts and Molds (2021) · cites this paper as [54]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
The citation lists are queued
They are fetched later and appear here then.
References 28 · Cited by 139
Research works printed but not linked: 4
- Hata K, Horii T, Miyazaki M, Watanabe NA. 2011. In vitro and in vivo antifungal activities of E1211, a water-soluble prodrug of E1210. Intersci Conf Antimicrob Agents Chemother, abstr F1-1377.
- Watanabe NA, Horii T, Miyazaki M, Hata K. 2011. In vitro activity of E1210 and in vivo activity of E1211, a water-soluble prodrug of E1210, in combination with other antifungals. Intersci Conf Antimicrob Agents Chemother, abstr F1-1378.
- CLSI. 2016. Epidemiological cutoff values for antifungal susceptibility testing, 1st ed, supplement M59. Clinical and Laboratory Standards Institute, Wayne, PA.
- CLSI. 2008. Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard, 3rd ed. Document M27-A3. Clinical and Laboratory Standards Institute, Wayne, PA.
Metadata
- Authors
- Hager, C. L., Larkin, E. L., Long, L., Zohra Abidi, F., Shaw, K. J., & Ghannoum, M. A.
- Affiliations
- University Hospitals Cleveland Medical Center (US)
- Center for Medical Mycology, University Hospitals Cleveland Medical Center and Case Western Reserve University, Cleveland, Ohio, USA
- Amplyx Pharmaceuticals (United States) (US)
- Corresponding author
- Ghannoum, Mahmoud A.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2018-03
- Volume
- 62
- Issue
- 3
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- PMC
- PMC5826120
- OpenAlex
- W2783397783
- Cited by
- 139
- References
- 28
- Citations by year
- 2026: 7 · 2025: 7 · 2024: 6 · 2023: 18 · 2022: 19 · 2021: 24 · 2020: 22 · 2019: 20 · 2018: 16
- FWCI
- 15.49
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (vor)
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Antimicrobial Agents and Chemotherapy (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Agricultural and Biological Sciences › Plant Science › Fungal Plant Pathogen Control
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Keywords
- Candida auris, antifungal agents, multidrug resistance, antifungal susceptibility, prodrugs, systemic candidiasis, anidulafungin, emerging fungal pathogens
- MeSH terms
- Anidulafungin, Aminopyridines, Amphotericin B, Animals, Antifungal Agents, Brain, Candida, Candidiasis, Dose-Response Relationship, Drug, Female, Isoxazoles, Kidney, Lung, Microbial Sensitivity Tests, Prodrugs, Fluconazole, Survival Analysis, Immunocompromised Host, Mice, Echinocandins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: In Vitro and In Vivo Evaluation of the Antifungal Activity of APX001A/APX001 against Candida auris. https://app.cochat.ai/papers/10.1128/aac.02319-17
- The paper
- Hager, C. L., Larkin, E. L., Long, L., Zohra Abidi, F., Shaw, K. J., & Ghannoum, M. A. (2018). In Vitro and In Vivo Evaluation of the Antifungal Activity of APX001A/APX001 against Candida auris. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.02319-17
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.